TABLE 3.
Major propensity profile peaks from human adenovirus type 5 promoters
| Relative bp
|
|||
|---|---|---|---|
| Max p (×10−4) | Peak range | Peak max | |
| E1A | 2.860 | −137 to −124 | −134 |
| 4.078 | −108 to −96 | −100 | |
| 9.438 | −69 to −53 | −60 | |
| 5.556 | −43 to −26 | −35 | |
| 3.139 | +13 to +26 | +20 | |
| E1B | 7.225 | −144 to −130 | −136 |
| 5.285 | −99 to −91 | −95 | |
| 4.480 | −73 to −57 | −68 | |
| 5.568 | −35 to −17 | −29 | |
| 3.631 | +2 to +36 | +23 | |
| E2E | 4.193 | −129 to −119 | −124 |
| 3.442 | −71 to −63 | −67 | |
| 4.747 | −62 to −52 | −56 | |
| 5.610 | −51 to −44 | −48 | |
| 3.930 | −30 to −19 | −26 | |
| 4.400 | −6 to +10 | +2 | |
| E3 | 2.141 | −135 to −122 | −131 |
| 3.900 | −102 to −91 | −97 | |
| 1.557 | −62 to −56 | −58 | |
| 3.537 | −31 to −16 | −24 | |
| 2.809 | −4 to +11 | +4 | |
| E4 | 3.927 | −134 to −124 | −128 |
| 4.117 | −123 to −114 | −119 | |
| 4.161 | −113 to −103 | −108 | |
| 4.251 | −73 to −65 | −69 | |
| 5.604 | −64 to −53 | −59 | |
| 6.667 | −44 to −37 | −39 | |
| 8.770 | −36 to −23 | −30 | |
| 4.784 | −1 to +18 | +8 | |
| E2L | 3.266 | −147 to −134 | −139 |
| 3.185 | −133 to −123 | −127 | |
| 1.972 | −89 to −85 | −87 | |
| 3.743 | −64 to −49 | −56 | |
| 4.028 | −29 to −19 | −21 | |
| 4.157 | −18 to −12 | −17 | |
| 2.258 | +18 to +27 | +22 | |
| IX | 4.910 | −155 to −128 | −145 |
| 6.486 | −102 to −89 | −95 | |
| 7.097 | −76 to −59 | −70 | |
| 4.638 | −11 to +10 | −1 | |
| 2.485 | +41 to +48 | +46 | |
| MLP | 1.787 | −150 to −138 | −144 |
| 2.597 | −115 to −102 | −109 | |
| 3.718 | −83 to −62 | −70 | |
| 2.228 | −32 to −18 | −28 | |
| 1.974 | +2 to +20 | +8 | |
| 1.958 | +44 to +50 | +48 | |
| IVa2 | 3.718 | −149 to −128 | −141 |
| 2.597 | −112 to −96 | −102 | |
| 1.769 | −73 to −60 | −68 | |
| 1.915 | −6 to −36 | −40 | |
| 2.542 | −11 to +1 | −5 | |
| 3.189 | +2 to +21 | +15 | |
Peak range was determined using peak widths at 50% of maximum peak values above an assumed baseline of p = 0.0001.